insights_auto
Pse është ulur ALMKT 2,74%?
Zhytu më thellëchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
arrow_downward
-2,74%(-0,0026) 1D
12 nën, 5:35:12 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,10 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,92 mln
Vëllimi mesatar
545,11 mijë
Vëllimi
189,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Hap
0,10 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,92 mln
Vëllimi mesatar
545,11 mijë
Vëllimi
189,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Eurasia Business News
·
2 orë më parë
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
Investing.com
·
4 orë më parë
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
ChartMill
·
7 orë më parë
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
4 orë më parë
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustriaMedical device
Uebsajtimaunakeatech.com